ZYME übertreffen die 23 der letzten 34Schätzungen.
68%
Nächster Bericht
Datum des nächsten Berichts
03. März 2026
Estimate forQ4 25(Revenue/ EPS)
$14.13M
/
-$0.43
Implizierte Änderung vonQ3 25(Revenue/ EPS)
-48.84%
/
+65.38%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
-54.48%
/
+38.71%
Zymeworks Inc. earnings per share and revenue
On 06. Nov. 2025, ZYME reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 20.63% surprise. Revenue reached 27.61 million, compared to an expected 30.05 million, with a -8.10% difference. The market reacted with a -8.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 14.13 million USD, implying an increase of 65.38% EPS, and decrease of -48.84% in Revenue from the last quarter.
FAQ
What were Zymeworks Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zymeworks Inc. reported EPS of -$0.26, beating estimates by 20.63%, and revenue of $27.61M, -8.1% below expectations.
How did the market react to Zymeworks Inc.'s Q3 2025 earnings?
The stock price moved down -8.04%, changed from $17.90 before the earnings release to $16.46 the day after.
When is Zymeworks Inc. expected to report next?
The next earning report is scheduled for 03. März 2026.
What are the forecasts for Zymeworks Inc.'s next earnings report?
Based on 14
analysts, Zymeworks Inc. is expected to report EPS of -$0.43 and revenue of $14.13M for Q4 2025.